The global HLA typing market is expected to expand at a compound annual growth rate (CAGR) of approximately 6% during the ...
KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Genomind®, the leader in comprehensive genetics and digital mental health services, has pioneered a new level of specificity and accuracy for cheek swab-based ...
Please provide your email address to receive an email when new articles are posted on . The FDA granted de novo classification to the SeCore CDx HLA Sequencing System for use as a companion diagnostic ...
CHICAGO--(BUSINESS WIRE)--Tempus, a leader in artificial intelligence and precision medicine, today announced that the U.S. Food & Drug Administration (FDA) has granted the company Breakthrough Device ...
DUBLIN, March 18, 2020 /PRNewswire/ -- The "HLA Typing Market by Technology (PCR, NGS, Sanger Sequencing), Product (Instrument, Reagent), Application (Cancer Research, Infectious & Non Infectious ...
QIAGEN has announced that it has entered into an agreement with the Dutch molecular diagnostic component supplier Genome Diagnostics which covers the development and commercialization of 6 new tests ...
Deal includes assets, infrastructure, and sales team related to the Olerup SSP line. LinkMed is taking over distribution rights to Qiagen’s Olerup SSP® product line, which consists of genomic HLA ...
ShardaCare Healthcity, a leading super-speciality hospital in Greater Noida, renowned for its advanced clinical capabilities and patient-centric approach, is organising a bone marrow transplant (BMT) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results